Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Blood
|
September 23, 2006
Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis
Jack L Arbiser, Tweeny Kau, Martha Konar, et al.
Science Immunology
|
December 20, 2024
Extrasinusoidal macrophages are a distinct subset of immunologically active dural macrophages
Lukas Amann, Amelie Fell, Gianni Monaco, et al.
The Journal of Experimental Medicine
|
January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplant
Adam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
Nature Neuroscience
|
July 14, 2025
Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer's disease
Alberto Ardura-Fabregat, Lance Fredrick Pahutan Bosch, Emile Wogram, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR
Christiana Iwuagwu, Dalton King, Ivar M McDonald, et al.
Science (New York, N.Y.)
|
October 14, 2021
Mapping the proteo-genomic convergence of human diseases
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Journal of Veterinary Medical Education
|
September 13, 2003
US agriculture is vulnerable to bioterrorism
Harley W Moon, Charlotte Kirk-Baer, Michael Ascher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 18, 2021
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation
Jack Rivers-Auty, Victor S Tapia, Claire S White, et al.
ACS Medicinal Chemistry Letters
|
January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists
Matthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One
|
July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Linda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Blood
|
September 23, 2006
Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis
Jack L Arbiser, Tweeny Kau, Martha Konar, et al.
Science Immunology
|
December 20, 2024
Extrasinusoidal macrophages are a distinct subset of immunologically active dural macrophages
Lukas Amann, Amelie Fell, Gianni Monaco, et al.
The Journal of Experimental Medicine
|
January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplant
Adam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
Nature Neuroscience
|
July 14, 2025
Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer's disease
Alberto Ardura-Fabregat, Lance Fredrick Pahutan Bosch, Emile Wogram, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR
Christiana Iwuagwu, Dalton King, Ivar M McDonald, et al.
Science (New York, N.Y.)
|
October 14, 2021
Mapping the proteo-genomic convergence of human diseases
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Journal of Veterinary Medical Education
|
September 13, 2003
US agriculture is vulnerable to bioterrorism
Harley W Moon, Charlotte Kirk-Baer, Michael Ascher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 18, 2021
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation
Jack Rivers-Auty, Victor S Tapia, Claire S White, et al.
ACS Medicinal Chemistry Letters
|
January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists
Matthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One
|
July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Linda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Page
of 20